Use of PPAR delta ligands for the treatment or prevention of inflammation or energy metabolism/production related diseases

Details for Australian Patent Application No. 2010282399 (hide)

Owner Cerenis Therapeutics S.A. Nippon Chemiphar Co., Ltd.

Inventors Barbaras, Ronald; Oniciu, Daniela Carmen; Dasseux, Jean-Louis; Scott, Robert A.; Wetterau, John R.

Agent HENRY HUGHES LIMITED

Pub. Number AU-A-2010282399

PCT Pub. Number WO2011/020001

Priority 61/234,231 14.08.09 US; 61/251,655 14.10.09 US

Filing date 13 August 2010

Wipo publication date 17 February 2011

International Classifications

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/382 (2006.01) - having six-membered rings, e.g. thioxanthenes

A61K 31/42 (2006.01) - Oxazoles

A61K 31/421 (2006.01) - 1,3-Oxazoles, e.g. pemoline, trimethadione

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/426 (2006.01) - 1,3-Thiazoles

Event Publications

1 March 2012 PCT application entered the National Phase

  PCT publication WO2011/020001 Priority application(s): WO2011/020001

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010282402-Filled polyurethane composites and methods of making same

2010282397-Tetrahydro-isoalpha acid compositions and methods for weight management